Martin Joins Valent BioSciences Corporation as Manager, Global Field Research and Development

[vc_row][vc_column][vc_column_text]

FOR IMMEDIATE RELEASE

LIBERTYVILLE, IL, June 21, 2013 – Valent BioSciences Corporation (VBC) announced that Dr. Randy Martin has joined the company as Manager of the global Field Research and Development group. In his new role, Martin will assume responsibility for certain of the company’s field R&D activities directed toward the worldwide development of new biorational products and their uses in agriculture.

VBC is the leader in developing and commercializing biorational products in 95 countries around the world. Biorationals are products typically derived from biological origins (natural or synthesized) that are highly specific in their activity while providing economic, health, and/or environmental benefits. These products include microbial insecticides, fungicides and nematicides, as well as plant growth regulators used in seed treatment, production agriculture, postharvest and management of stress in crops.

Martin will report to Dr. Warren Shafer, Vice President, Global R&D and Regulatory Affairs. According to Shafer, “The addition of Randy to our team comes at critical time in the growth of our company. As we continue to build our broad portfolio of biorational solutions, his leadership of our global Field R&D team will have an immediate impact on the development of new opportunities for our business.”

Prior to this role at VBC, Martin has had a successful career with several global crop protection companies in various R&D roles including product and market development, technical product support, and project and portfolio management. Martin has a Ph.D. in Entomology from Texas A&M University.

“I am excited about the opportunities for VBC and the other Sumitomo Chemical affiliate companies around the world,” Martin said. “VBC has earned its reputation as the global leader in biorational product development, and its robust pipeline speaks to the company’s clear vision for the future and commitment to its customers worldwide.”

Martin will be headquartered in the Valent BioSciences offices in Libertyville, IL.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company. Valent BioSciences is the worldwide leader in the development, manufacturing and commercialization of biorational products, with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

About Sumitomo Chemical Company, Limited
Sumitomo Chemical Company is one of Japan’s leading chemical companies, offering a diverse range of products globally in the fields of basic chemicals, petrochemicals, IT- related chemicals and materials, health and crop science products, and pharmaceuticals. For additional information, visit the company’s website at www.sumitomo-chem.co.jp/english/.

Media Contact:
Rick Melnick
Valent BioSciences Corporation 847-968-4750
Email: rick.melnick@valentbiosciences.com

Download News Release

[/vc_column_text][/vc_column][/vc_row]

Share:

Related News

Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forest health, has announced that the company began selling biostimulant products directly to its U.S. customer base on October 1.
Sumitomo Chemical Co., Ltd. (SCC), parent company of Valent U.S.A. and Valent Biosciences, today announced a new entity called Valent North America that will provide enterprise business services across the Valent group of companies. 
Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forestry, has announced the promotion of Salman Mir to Executive Vice President and Chief Operating Officer. He will continue reporting to Ted Melnik, Valent BioSciences’ President and Chief Executive Officer.
To promote its industry leadership in biorational and biostimulant product innovation, Valent BioSciences LLC has announced significant investments at several of its key research and development facilities.
Valent BioSciences LLC announced today that it has approved a major expansion of its biorational manufacturing facility in Osage, Iowa, which will meet increasing demand for its biorational products and the introduction of new products requiring more capacity.
The U.S. Environmental Protection Agency recently granted Valent BioSciences LLC an Experimental Use Permit (EUP) to perform further field studies of VBC-60748, a new mosquito space spray targeting pyrethroid-resistant adult mosquitoes.